At our US Research & Early Development (R&ED) organization, we are dedicated to pushing the boundaries of what is possible to improve global health. With one of our two integrated global R&ED hubs located in Boston (the other in Copenhagen, Denmark), our teams possess extensive end-to-end capabilities. These capabilities encompass coexisting discovery, research, and innovative technologies across the full value chain of research and clinical development.

Our focus is on tackling some of the most pressing chronic diseases, including obesity, diabetes, cardiovascular diseases, and rare blood disorders. By leading the charge in groundbreaking science, we aim to better serve patients and drive meaningful change in the healthcare landscape.

We offer the full spectrum of R&D from discovery science to early development, all with the goal of expanding our pipeline to better serve patients. We utilize a patient-centric approach to discover new medicines and identify ways to make existing medicines better across our focused disease areas.

Our capabilities are bolstered by the integration of human and AI data, which allows us to gain deeper insights and accelerate the drug discovery process. 

 


Our researchers work across several disease areas to uncover insights into the origins and pathogenesis of diseases. This foundational work drives drug discovery and early development, setting the stage for groundbreaking treatments.

 


Our innovative efforts are powered by technology platforms that help us push the boundaries across our core therapeutic areas. We focus on these platforms, which we believe will play an increasingly important role in delivering new medicines for patients:

  • RNAi platforms utilizing GalXc molecules: These platforms enable precise gene silencing, offering a powerful approach to target and treat diseases at the molecular level.

 


By leveraging these advanced platforms, we are committed to continuing our legacy of innovation. Our goal is to deliver new, life-changing medicines that address unmet medical needs and improve the health and well-being of people around the world.

Together, we are driving change for generations to come, transforming scientific ideas into life-saving medicines and treatment solutions. We believe in the power of technology and innovation to create a world free from the burden of chronic disease.